Join IceCure at ASBrS 2026: Cryoablation for Breast Cancer in Low-Risk Patients
Sign Up Now for Our Exclusive Breakfast Symposium & Connect With the IceCure Team! Are you a breast surgeon looking for innovative, minimally invasive treatment options for low-risk breast cancer? Don’t miss your chance to discover the latest breakthroughs in breast cryoablation with ProSense® at the American Society of Breast Surgeons Annual Meeting in Seattle, WA, from April 30 – May 3, 2026. […]
Discover IceCure Breast Cryoablation at ECIO 2026: Join us at the European Conference on Interventional Oncology in Basel
Join IceCure at the European Conference on Interventional Oncology (ECIO) in Basel, Switzerland from April 26 – 30. Discover how our liquid nitrogen-based ProSense™ Cryoablation system is giving clinicians new choices in interventional oncology at Booth #4. IceCure is proud to be a silver sponsor at ECIO 2026, one of the leading global meetings dedicated to minimally invasive image-guided cancer […]
IceCure at SBI 2026 Symposium: Discover ProSense® Cryoablation for Breast Tumors
Visit us at Booth 817 during the SBI Breast Imaging Symposium to explore cryoablation for low-risk breast cancers and fibroadenoma.
IceCure to Exhibit at 2025 American Society of Breast Surgeons (ASBrS) Annual Meeting
IceCure is excited to be exhibiting at the American Society of Breast Surgeons (ASBrS) 2025 annual meeting in Las Vegas, Nevada from April 30 – May 4. We invite you to Booth 212 to learn how you can empower your practice with the choice of cryoablation for breast tumors. ProSense® Cryoablation System & the ICE3 […]
IceCure to Exhibit at the 2025 Society of Breast Imaging (SBI) Symposium
IceCure is thrilled to be exhibiting at the 40th anniversary Society of Breast Imaging Annual Symposium in Colorado Springs, CO from April 24 – April 27. Join IceCure at Booth 237 for a host of exciting opportunities for breast radiologists to learn about breast cryoablation with the ProSense® System. ProSense® is a liquid nitrogen-based cryoablation […]
IceCure to Exhibit and Join the Hands-on Cryoablation Sessions at the European Conference on Interventional Oncology (ECIO) 2025
IceCure Medical is excited to be a Silver Sponsor at the European Conference on Interventional Oncology (ECIO) 2025. The conference is taking place from April 13 – April 16, in Rotterdam, Netherlands. Visit IceCure at Booth 17 for the opportunity to learn about our advanced liquid nitrogen cryoablation technology, the ProSense™ System. ProSense™ Cryoablation at […]
Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients
A study showing that cryoablation allows the ultimate de-escalation of surgical therapy for select breast cancer patients.
Assessing the Outcome of Cryoablation Treatment on Different Molecular Subtypes of Low-Grade Breast Cancer
Study assessing the outcome of cryoablation treatment on different molecular subtypes of low-grade breast cancer.
Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study
Study on the cryoablation of primary breast cancer in patients ineligible for clinical trials: a multi-institutional study.
Cryoablation Therapy for Early-Stage Breast Cancer: Evidence and Rationale
This publication provides a comprehensive evaluation of cryoablation as a non-surgical alternative to traditional breast-conserving surgery for early-stage breast cancer.